Beurer medical GL 48 Gebrauchsanweisung Seite 36

Beeinflussung
Konzentration der
getesteten Substanzen
Icodextrin 2000 mg/dL
L-Dopa 0.7 mg/dL
Maltose 1000 mg/dL
Methyl-DOPA
0.625 mg/dL (0.03 mmol/L)
Pralidoxiniodid 5 mg/dL
Natriumsalicylat 160 mg/dL
Salicylsäure 60 mg/dL
Tolbutamid 64 mg/dL
Tolazamid 6.25 mg/dL
Triglyceride 3000 mg/dL
Harnsäure
10 mg/dL
Xylose 6.25 mg/dL
36
Blutzuckerwert
50-100 mg/dL
(2,8-5,6 mmol/L)
(111 mmol/L) -3.7 mg/dL
(-0.20 mmol/L)
(0.04 mmol/L)
(0.31 mmol/L)
(55.53 mmol/L)
(0.14 mmol/L)
(0.33 mmol/L)
(0.28 mmol/L)
(0.32 mmol/L)
(8.88 mmol/L) -6.2 mg/dL
(-0.34 mmol/L)
(3.33 mmol/L)
(0.13 mmol/L)
(3.55 mmol/L) -1.0 mg/dL
(-0.05 mmol/L)
(0.35 mmol/L)
(0.32 mmol/L)
(166.59 mmol/L)
(0.31 mmol/L)
(0.56 mmol/L)
(0.3 mmol/L)
(0.35 mmol/L)
(0.31 mmol/L)
250-350 mg/dL
(13.9-19.4 mmol/L)
-6.1%
5.6 mg/dL
2.5 mg/dL
6.0 mg/dL
5.8 mg/dL
-5.0%
2.4 mg/dL
-2.6%
5.8 mg/dL
5.6 mg/dL
5.4 mg/dL
5.5 mg/dL
6.6%
4.5%
6.9%
6.4%
2.5%
6.3%
6.5%
5.6%
7.3%
Beurer GL48